- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
According to our latest study, the global Tuberculosis Vaccine Treatment market size was valued at USD 76 million in 2022 and is forecast to a readjusted size of USD 92 million by 2029 with a CAGR of 2.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
This report is a detailed and comprehensive analysis for global Tuberculosis Vaccine Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Tuberculosis Vaccine Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/K Dose), 2018-2029
Global Tuberculosis Vaccine Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/K Dose), 2018-2029
Global Tuberculosis Vaccine Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/K Dose), 2018-2029
Global Tuberculosis Vaccine Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (USD/K Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tuberculosis Vaccine Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tuberculosis Vaccine Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines and BioFarma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Tuberculosis Vaccine Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immune Vaccine
Therapy Vaccine
Market segment by Application
Self-Procurement
UNICEF
Other
Major players covered
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tuberculosis Vaccine Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tuberculosis Vaccine Treatment, with price, sales, revenue and global market share of Tuberculosis Vaccine Treatment from 2018 to 2023.
Chapter 3, the Tuberculosis Vaccine Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tuberculosis Vaccine Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tuberculosis Vaccine Treatment market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tuberculosis Vaccine Treatment.
Chapter 14 and 15, to describe Tuberculosis Vaccine Treatment sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Tuberculosis Vaccine Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Tuberculosis Vaccine Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Immune Vaccine
1.3.3 Therapy Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Tuberculosis Vaccine Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Self-Procurement
1.4.3 UNICEF
1.4.4 Other
1.5 Global Tuberculosis Vaccine Treatment Market Size & Forecast
1.5.1 Global Tuberculosis Vaccine Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Tuberculosis Vaccine Treatment Sales Quantity (2018-2029)
1.5.3 Global Tuberculosis Vaccine Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Tuberculosis Vaccine Treatment Product and Services
2.1.4 Merck Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Japan BCG Lab
2.2.1 Japan BCG Lab Details
2.2.2 Japan BCG Lab Major Business
2.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Product and Services
2.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Japan BCG Lab Recent Developments/Updates
2.3 Serum Institute of India
2.3.1 Serum Institute of India Details
2.3.2 Serum Institute of India Major Business
2.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Product and Services
2.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Serum Institute of India Recent Developments/Updates
2.4 AJ Vaccines
2.4.1 AJ Vaccines Details
2.4.2 AJ Vaccines Major Business
2.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Product and Services
2.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AJ Vaccines Recent Developments/Updates
2.5 BioFarma
2.5.1 BioFarma Details
2.5.2 BioFarma Major Business
2.5.3 BioFarma Tuberculosis Vaccine Treatment Product and Services
2.5.4 BioFarma Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 BioFarma Recent Developments/Updates
2.6 GreenSignal Bio Pharma
2.6.1 GreenSignal Bio Pharma Details
2.6.2 GreenSignal Bio Pharma Major Business
2.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product and Services
2.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GreenSignal Bio Pharma Recent Developments/Updates
2.7 China National Biotec
2.7.1 China National Biotec Details
2.7.2 China National Biotec Major Business
2.7.3 China National Biotec Tuberculosis Vaccine Treatment Product and Services
2.7.4 China National Biotec Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 China National Biotec Recent Developments/Updates
2.8 Biomed Lublin
2.8.1 Biomed Lublin Details
2.8.2 Biomed Lublin Major Business
2.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Product and Services
2.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Biomed Lublin Recent Developments/Updates
2.9 Taj Pharmaceuticals
2.9.1 Taj Pharmaceuticals Details
2.9.2 Taj Pharmaceuticals Major Business
2.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product and Services
2.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Taj Pharmaceuticals Recent Developments/Updates
2.10 Ataulpho de Paiva
2.10.1 Ataulpho de Paiva Details
2.10.2 Ataulpho de Paiva Major Business
2.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product and Services
2.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Ataulpho de Paiva Recent Developments/Updates
2.11 IVAC
2.11.1 IVAC Details
2.11.2 IVAC Major Business
2.11.3 IVAC Tuberculosis Vaccine Treatment Product and Services
2.11.4 IVAC Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 IVAC Recent Developments/Updates
2.12 Queen Saovabha Mem. Inst
2.12.1 Queen Saovabha Mem. Inst Details
2.12.2 Queen Saovabha Mem. Inst Major Business
2.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product and Services
2.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
2.13 Microgen
2.13.1 Microgen Details
2.13.2 Microgen Major Business
2.13.3 Microgen Tuberculosis Vaccine Treatment Product and Services
2.13.4 Microgen Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Microgen Recent Developments/Updates
3 Competitive Environment: Tuberculosis Vaccine Treatment by Manufacturer
3.1 Global Tuberculosis Vaccine Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Tuberculosis Vaccine Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Tuberculosis Vaccine Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Tuberculosis Vaccine Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Tuberculosis Vaccine Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Tuberculosis Vaccine Treatment Manufacturer Market Share in 2022
3.5 Tuberculosis Vaccine Treatment Market: Overall Company Footprint Analysis
3.5.1 Tuberculosis Vaccine Treatment Market: Region Footprint
3.5.2 Tuberculosis Vaccine Treatment Market: Company Product Type Footprint
3.5.3 Tuberculosis Vaccine Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Tuberculosis Vaccine Treatment Market Size by Region
4.1.1 Global Tuberculosis Vaccine Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Tuberculosis Vaccine Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Tuberculosis Vaccine Treatment Average Price by Region (2018-2029)
4.2 North America Tuberculosis Vaccine Treatment Consumption Value (2018-2029)
4.3 Europe Tuberculosis Vaccine Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Tuberculosis Vaccine Treatment Consumption Value (2018-2029)
4.5 South America Tuberculosis Vaccine Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Tuberculosis Vaccine Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Tuberculosis Vaccine Treatment Sales Quantity by Type (2018-2029)
5.2 Global Tuberculosis Vaccine Treatment Consumption Value by Type (2018-2029)
5.3 Global Tuberculosis Vaccine Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Tuberculosis Vaccine Treatment Sales Quantity by Application (2018-2029)
6.2 Global Tuberculosis Vaccine Treatment Consumption Value by Application (2018-2029)
6.3 Global Tuberculosis Vaccine Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Tuberculosis Vaccine Treatment Sales Quantity by Type (2018-2029)
7.2 North America Tuberculosis Vaccine Treatment Sales Quantity by Application (2018-2029)
7.3 North America Tuberculosis Vaccine Treatment Market Size by Country
7.3.1 North America Tuberculosis Vaccine Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Tuberculosis Vaccine Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Tuberculosis Vaccine Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Tuberculosis Vaccine Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Tuberculosis Vaccine Treatment Market Size by Country
8.3.1 Europe Tuberculosis Vaccine Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Tuberculosis Vaccine Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Tuberculosis Vaccine Treatment Market Size by Region
9.3.1 Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Tuberculosis Vaccine Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Tuberculosis Vaccine Treatment Sales Quantity by Type (2018-2029)
10.2 South America Tuberculosis Vaccine Treatment Sales Quantity by Application (2018-2029)
10.3 South America Tuberculosis Vaccine Treatment Market Size by Country
10.3.1 South America Tuberculosis Vaccine Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Tuberculosis Vaccine Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Tuberculosis Vaccine Treatment Market Size by Country
11.3.1 Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Tuberculosis Vaccine Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Tuberculosis Vaccine Treatment Market Drivers
12.2 Tuberculosis Vaccine Treatment Market Restraints
12.3 Tuberculosis Vaccine Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Tuberculosis Vaccine Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Tuberculosis Vaccine Treatment
13.3 Tuberculosis Vaccine Treatment Production Process
13.4 Tuberculosis Vaccine Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Tuberculosis Vaccine Treatment Typical Distributors
14.3 Tuberculosis Vaccine Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Tuberculosis Vaccine Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Tuberculosis Vaccine Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Tuberculosis Vaccine Treatment Product and Services
Table 6. Merck Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 9. Japan BCG Lab Major Business
Table 10. Japan BCG Lab Tuberculosis Vaccine Treatment Product and Services
Table 11. Japan BCG Lab Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Japan BCG Lab Recent Developments/Updates
Table 13. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 14. Serum Institute of India Major Business
Table 15. Serum Institute of India Tuberculosis Vaccine Treatment Product and Services
Table 16. Serum Institute of India Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Serum Institute of India Recent Developments/Updates
Table 18. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 19. AJ Vaccines Major Business
Table 20. AJ Vaccines Tuberculosis Vaccine Treatment Product and Services
Table 21. AJ Vaccines Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. AJ Vaccines Recent Developments/Updates
Table 23. BioFarma Basic Information, Manufacturing Base and Competitors
Table 24. BioFarma Major Business
Table 25. BioFarma Tuberculosis Vaccine Treatment Product and Services
Table 26. BioFarma Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. BioFarma Recent Developments/Updates
Table 28. GreenSignal Bio Pharma Basic Information, Manufacturing Base and Competitors
Table 29. GreenSignal Bio Pharma Major Business
Table 30. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product and Services
Table 31. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. GreenSignal Bio Pharma Recent Developments/Updates
Table 33. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 34. China National Biotec Major Business
Table 35. China National Biotec Tuberculosis Vaccine Treatment Product and Services
Table 36. China National Biotec Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. China National Biotec Recent Developments/Updates
Table 38. Biomed Lublin Basic Information, Manufacturing Base and Competitors
Table 39. Biomed Lublin Major Business
Table 40. Biomed Lublin Tuberculosis Vaccine Treatment Product and Services
Table 41. Biomed Lublin Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Biomed Lublin Recent Developments/Updates
Table 43. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Taj Pharmaceuticals Major Business
Table 45. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product and Services
Table 46. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Taj Pharmaceuticals Recent Developments/Updates
Table 48. Ataulpho de Paiva Basic Information, Manufacturing Base and Competitors
Table 49. Ataulpho de Paiva Major Business
Table 50. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product and Services
Table 51. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Ataulpho de Paiva Recent Developments/Updates
Table 53. IVAC Basic Information, Manufacturing Base and Competitors
Table 54. IVAC Major Business
Table 55. IVAC Tuberculosis Vaccine Treatment Product and Services
Table 56. IVAC Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. IVAC Recent Developments/Updates
Table 58. Queen Saovabha Mem. Inst Basic Information, Manufacturing Base and Competitors
Table 59. Queen Saovabha Mem. Inst Major Business
Table 60. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product and Services
Table 61. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Queen Saovabha Mem. Inst Recent Developments/Updates
Table 63. Microgen Basic Information, Manufacturing Base and Competitors
Table 64. Microgen Major Business
Table 65. Microgen Tuberculosis Vaccine Treatment Product and Services
Table 66. Microgen Tuberculosis Vaccine Treatment Sales Quantity (K Dose), Average Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Microgen Recent Developments/Updates
Table 68. Global Tuberculosis Vaccine Treatment Sales Quantity by Manufacturer (2018-2023) & (K Dose)
Table 69. Global Tuberculosis Vaccine Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Tuberculosis Vaccine Treatment Average Price by Manufacturer (2018-2023) & (USD/K Dose)
Table 71. Market Position of Manufacturers in Tuberculosis Vaccine Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Tuberculosis Vaccine Treatment Production Site of Key Manufacturer
Table 73. Tuberculosis Vaccine Treatment Market: Company Product Type Footprint
Table 74. Tuberculosis Vaccine Treatment Market: Company Product Application Footprint
Table 75. Tuberculosis Vaccine Treatment New Market Entrants and Barriers to Market Entry
Table 76. Tuberculosis Vaccine Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Tuberculosis Vaccine Treatment Sales Quantity by Region (2018-2023) & (K Dose)
Table 78. Global Tuberculosis Vaccine Treatment Sales Quantity by Region (2024-2029) & (K Dose)
Table 79. Global Tuberculosis Vaccine Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Tuberculosis Vaccine Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Tuberculosis Vaccine Treatment Average Price by Region (2018-2023) & (USD/K Dose)
Table 82. Global Tuberculosis Vaccine Treatment Average Price by Region (2024-2029) & (USD/K Dose)
Table 83. Global Tuberculosis Vaccine Treatment Sales Quantity by Type (2018-2023) & (K Dose)
Table 84. Global Tuberculosis Vaccine Treatment Sales Quantity by Type (2024-2029) & (K Dose)
Table 85. Global Tuberculosis Vaccine Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Tuberculosis Vaccine Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Tuberculosis Vaccine Treatment Average Price by Type (2018-2023) & (USD/K Dose)
Table 88. Global Tuberculosis Vaccine Treatment Average Price by Type (2024-2029) & (USD/K Dose)
Table 89. Global Tuberculosis Vaccine Treatment Sales Quantity by Application (2018-2023) & (K Dose)
Table 90. Global Tuberculosis Vaccine Treatment Sales Quantity by Application (2024-2029) & (K Dose)
Table 91. Global Tuberculosis Vaccine Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Tuberculosis Vaccine Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Tuberculosis Vaccine Treatment Average Price by Application (2018-2023) & (USD/K Dose)
Table 94. Global Tuberculosis Vaccine Treatment Average Price by Application (2024-2029) & (USD/K Dose)
Table 95. North America Tuberculosis Vaccine Treatment Sales Quantity by Type (2018-2023) & (K Dose)
Table 96. North America Tuberculosis Vaccine Treatment Sales Quantity by Type (2024-2029) & (K Dose)
Table 97. North America Tuberculosis Vaccine Treatment Sales Quantity by Application (2018-2023) & (K Dose)
Table 98. North America Tuberculosis Vaccine Treatment Sales Quantity by Application (2024-2029) & (K Dose)
Table 99. North America Tuberculosis Vaccine Treatment Sales Quantity by Country (2018-2023) & (K Dose)
Table 100. North America Tuberculosis Vaccine Treatment Sales Quantity by Country (2024-2029) & (K Dose)
Table 101. North America Tuberculosis Vaccine Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Tuberculosis Vaccine Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Tuberculosis Vaccine Treatment Sales Quantity by Type (2018-2023) & (K Dose)
Table 104. Europe Tuberculosis Vaccine Treatment Sales Quantity by Type (2024-2029) & (K Dose)
Table 105. Europe Tuberculosis Vaccine Treatment Sales Quantity by Application (2018-2023) & (K Dose)
Table 106. Europe Tuberculosis Vaccine Treatment Sales Quantity by Application (2024-2029) & (K Dose)
Table 107. Europe Tuberculosis Vaccine Treatment Sales Quantity by Country (2018-2023) & (K Dose)
Table 108. Europe Tuberculosis Vaccine Treatment Sales Quantity by Country (2024-2029) & (K Dose)
Table 109. Europe Tuberculosis Vaccine Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Tuberculosis Vaccine Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity by Type (2018-2023) & (K Dose)
Table 112. Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity by Type (2024-2029) & (K Dose)
Table 113. Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity by Application (2018-2023) & (K Dose)
Table 114. Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity by Application (2024-2029) & (K Dose)
Table 115. Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity by Region (2018-2023) & (K Dose)
Table 116. Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity by Region (2024-2029) & (K Dose)
Table 117. Asia-Pacific Tuberculosis Vaccine Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Tuberculosis Vaccine Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Tuberculosis Vaccine Treatment Sales Quantity by Type (2018-2023) & (K Dose)
Table 120. South America Tuberculosis Vaccine Treatment Sales Quantity by Type (2024-2029) & (K Dose)
Table 121. South America Tuberculosis Vaccine Treatment Sales Quantity by Application (2018-2023) & (K Dose)
Table 122. South America Tuberculosis Vaccine Treatment Sales Quantity by Application (2024-2029) & (K Dose)
Table 123. South America Tuberculosis Vaccine Treatment Sales Quantity by Country (2018-2023) & (K Dose)
Table 124. South America Tuberculosis Vaccine Treatment Sales Quantity by Country (2024-2029) & (K Dose)
Table 125. South America Tuberculosis Vaccine Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Tuberculosis Vaccine Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity by Type (2018-2023) & (K Dose)
Table 128. Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity by Type (2024-2029) & (K Dose)
Table 129. Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity by Application (2018-2023) & (K Dose)
Table 130. Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity by Application (2024-2029) & (K Dose)
Table 131. Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity by Region (2018-2023) & (K Dose)
Table 132. Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity by Region (2024-2029) & (K Dose)
Table 133. Middle East & Africa Tuberculosis Vaccine Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Tuberculosis Vaccine Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Tuberculosis Vaccine Treatment Raw Material
Table 136. Key Manufacturers of Tuberculosis Vaccine Treatment Raw Materials
Table 137. Tuberculosis Vaccine Treatment Typical Distributors
Table 138. Tuberculosis Vaccine Treatment Typical Customers
List of Figures
Figure 1. Tuberculosis Vaccine Treatment Picture
Figure 2. Global Tuberculosis Vaccine Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Tuberculosis Vaccine Treatment Consumption Value Market Share by Type in 2022
Figure 4. Immune Vaccine Examples
Figure 5. Therapy Vaccine Examples
Figure 6. Global Tuberculosis Vaccine Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Tuberculosis Vaccine Treatment Consumption Value Market Share by Application in 2022
Figure 8. Self-Procurement Examples
Figure 9. UNICEF Examples
Figure 10. Other Examples
Figure 11. Global Tuberculosis Vaccine Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Tuberculosis Vaccine Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Tuberculosis Vaccine Treatment Sales Quantity (2018-2029) & (K Dose)
Figure 14. Global Tuberculosis Vaccine Treatment Average Price (2018-2029) & (USD/K Dose)
Figure 15. Global Tuberculosis Vaccine Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Tuberculosis Vaccine Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Tuberculosis Vaccine Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Tuberculosis Vaccine Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Tuberculosis Vaccine Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Tuberculosis Vaccine Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Tuberculosis Vaccine Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Tuberculosis Vaccine Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Tuberculosis Vaccine Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Tuberculosis Vaccine Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Tuberculosis Vaccine Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Tuberculosis Vaccine Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Tuberculosis Vaccine Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Tuberculosis Vaccine Treatment Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Tuberculosis Vaccine Treatment Average Price by Type (2018-2029) & (USD/K Dose)
Figure 30. Global Tuberculosis Vaccine Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Tuberculosis Vaccine Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Tuberculosis Vaccine Treatment Average Price by Application (2018-2029) & (USD/K Dose)
Figure 33. North America Tuberculosis Vaccine Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Tuberculosis Vaccine Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Tuberculosis Vaccine Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Tuberculosis Vaccine Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Tuberculosis Vaccine Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Tuberculosis Vaccine Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Tuberculosis Vaccine Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Tuberculosis Vaccine Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Tuberculosis Vaccine Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Tuberculosis Vaccine Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Tuberculosis Vaccine Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Tuberculosis Vaccine Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Tuberculosis Vaccine Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Tuberculosis Vaccine Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Tuberculosis Vaccine Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Tuberculosis Vaccine Treatment Market Drivers
Figure 74. Tuberculosis Vaccine Treatment Market Restraints
Figure 75. Tuberculosis Vaccine Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Tuberculosis Vaccine Treatment in 2022
Figure 78. Manufacturing Process Analysis of Tuberculosis Vaccine Treatment
Figure 79. Tuberculosis Vaccine Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
